Technology | 2021.08.26
Trice Medical Receives Investment and International Distribution Partnership from Bioventus, Inc.
Trice Medical announced today that it received a strategic investment from Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing. In conjunction with leading the Series D funding round, Bioventus will receive exclusive sales and distribution rights to Trice’s products outside of the US. Trice Medical is known for its disruptive imaging technology that enables orthopedic procedures to be done on its portable, tablet-based system.
(PRWeb August 26, 2021)
Read the full story at https://www.prweb.com/releases/trice_medical_receives_investment_and_international_distribution_partnership_from_bioventus_inc/prweb18155378.htm
For more information, please visit
https://www.prweb.com/releases/trice_med[...]ioventus_inc/prweb18155378.htm
